Hepatitis B (HBV) and Hepatitis C (HCV) are significant global public health burdens associated with liver cirrhosis, liver cancer and are responsible for over a million deaths yearly. Prisons and other confined facilities offer opportunities for the acquisition and transmission of infectious diseases such as hepatitis B and C during and after imprisonment. This study aimed to investigate the seroprevalence of Hepatitis B and Hepatitis C as well as their associated risk factors among inmates in the Port Harcourt Maximum Security Custodial Centre. A cross-sectional study was conducted among inmates incarcerated in the Port Harcourt Maximum Security Custodial Centre from July to December 2022, and 200 consenting subjects completed a structured questionnaire in addition to screening for the presence of HBsAg and anti-HCV antibodies. Data generated from this study was represented as frequency and percentages, and inferential statistics were carried out using chi-square with the aid of GraphPad Prism Software Version 9. Statistical significance was defined as a p-value of less than 0.05 at a 95% confidence interval. The seroprevalence of HBV was 4% while 3.5% was recorded for HCV with no cases of co-infections reported. HBV seroprevalence was significantly associated with blood oath and a history of surgery (p < 0.05) while HCV seroprevalence was significantly associated with a history of blood oath, sex with non-marital partners as well as a history of illicit drug use (p < 0.05). The findings from the current study highlight a relatively lower prevalence of HBV and HCV amongst inmates in Port Harcourt in comparison to studies in Nigeria. These infections can be further controlled by multifaceted approaches by the prison personnel, administration, and Government by employing combative measures such as regular screening, easy access to therapy, awareness, and vaccination programs for HBV are crucial to prevent the transmission of these diseases.
References
[1]
Hellard, M.E., Hocking, J.S. and Crofts, N. (2004) The Prevalence and the Risk Behaviors Associated with the Transmission of Hepatitis C Virus in Australian Correctional Facilities. Epidemiology & Infection, 132, 409-415. https://doi.org/10.1017/S0950268803001882
[2]
El Saadany, S., Coyle, D., Giulivi, A. and Afzal, M. (2005) Economic Burden of Hepatitis C in Canada and the Potential Impact of Prevention: Results from a Disease Model. The European Journal of Health Economics, 6, 159-165. https://doi.org/10.1007/s10198-004-0273-y
[3]
Kutateladze, B.L., Andiloro, N.R., Johnson, B.D. and Spohn, C.C. (2014) Cumulative Disadvantage: Examining Racial and Ethnic Disparity in Prosecution and Sentencing. Criminology, 2, 514-551. https://doi.org/10.1111/1745-9125.12047
[4]
Niveau, G. (2006) Prevention of Infectious Disease Transmission in Correctional Settings: A Review. Public Health, 120, 33-41. https://doi.org/10.1016/j.puhe.2005.03.017
[5]
Weinbaum, C.M., Sabin, K.M. and Santibanez, S.S. (2005) Hepatitis B, Hepatitis C, and HIV in Correctional Populations: A Review of Epidemiology and Prevention. AIDS, 19, S41-S46. https://doi.org/10.1097/01.aids.0000192069.95819.aa
[6]
Mike-Ogburia, M.I., Vito-Peter, B., Hart, G.M., Dio, A., Nwogu, V.C., Okoro, O.C., Albert, O.C., Angala, P.O., Clifford, M.C., Ogbakiri, P.A. and Obunwo, C.O. (2023) The HIV and Syphilis Seroprevalence and Associated Risk Factors among Incarcerated Individuals in Port Harcourt. Journal of Infectious Diseases & Case Reports, 4, 1-13. https://doi.org/10.47363/JIDSCR/2023(4)171
[7]
Joshua, I. and Ojong, M. (2005) Prisoners: The Forgotten HIV/AIDS Risk Group. The New Times. https://allafrica.com/stories/200512030032.html
[8]
World Health Organization (2007) Health in Prisons. A WHO Guide to the Essentials in Prison Health. World Health Organization. http://www.euro.who.int/__data/assets/pdf_file/0009/99018/E90174.pdf
[9]
Dan-Nwafor, C.C., Adeoye, I., Aderemi, K., Onuoha, M., Adedire, E., Bashorun, A., Osunkwo, D., Gidado, S., Balogun, M., Idris, S. and Ade-Yusuf, I. (2021) Serological Markers and Risk Factors Associated with Hepatitis B Virus Infection among Federal Capital Territory Prison Inmates, Nigeria: Should We Be Concerned? PLOS ONE, 16, e0248045. https://doi.org/10.1371/journal.pone.0248045
[10]
Musa, B., Bussell, S., Borodo, M.M., Samaila, A.A. and Femi, O.L. (2015) PREVALENCE of Hepatitis B Virus Infection in Nigeria, 2000-2013: A Systematic Review and Meta-Analysis. Nigeria Journal of Clinical Practice, 18, 163-172.
[11]
World Health Organisation (2022) Hepatitis B. World Health Organisation. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b
[12]
Olayinka, A.T., Oyemakinde, A., Balogun, M.S., Ajudua, A., Nguku, P., Aderinola, M., Egwuenu-Oladejo, A., Ajisegiri, S.W., Sha’aibu, S., Musa, B.O. and Gidado, S. (2016) Seroprevalence of Hepatitis B Infection in Nigeria: A National Survey. American Journal of Tropical Medicine and Hygiene, 95, 902-907. https://doi.org/10.4269/ajtmh.15-0874
[13]
Dolan, K., Wirtz, A.L., Moazen, B., Ndeffo-Mbah, M., Galvani, A., Kinner, S.A., Courtney, R., McKee, M., Amon, J.J., Maher, L., Hellard, M., Beyrer, C. and Altice, F.L. (2016) Global Burden of HIV, Viral Hepatitis and Tuberculosis in Prisoners and Detainees. The Lancet, 388, 1089-1102. https://doi.org/10.1016/S0140-6736(16)30466-4
[14]
CDC (2003) Prevention and Control of Infections with Hepatitis Viruses in Correctional Settings. MMWR Recommendations and Reports, 52, 1-36.
[15]
Moradi, G., Goodarzi, E. and Khazaei, Z. (2018) Prevalence of Hepatitis B and C in Prisons Worldwide: A Meta-Analysis during the Years 2005-2015. Biomedical Research and Therapy, 5, 2235-2251. https://doi.org/10.15419/bmrat.v5i4.436
[16]
World Prison Brief (2021) Country-Nigeria. WPB. https://www.prisonstudies.org
[17]
Adoga, M.P., Banwat, E.B., Forbi, J.C., Nimzing, L., Pam, C.R., Gyar, S.D., Agabi, Y.A. and Agwale, S.M. (2009) Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus: Sero-Prevalence, Co-Infection and Risk Factors among Prison Inmates in Nasarawa State, Nigeria. The Journal of Infection in Developing Countries, 3, 539-547. https://doi.org/10.3855/jidc.472
[18]
Uchechukwu, O.F., Abdulrahman, Y., Aliyu, A.U., Mustaphar, U., Zama, I., Charles, A.T., Kwaifa, I., Ali, B.H., Augustine, O., Marafa, A. and Osaro, E. (2018) Seroprevalence of HIV, HBV and HCV among Prisoners in Sokoto, Nigeria. Asian Journal of Medicine and Health, 13, 1-8. https://doi.org/10.9734/AJMAH/2018/33128
[19]
Okafor, I.M., Ugwu, S.O. and Okoroiwu, H.U. (2020) Hepatitis C Virus Infection and Its Associated Factors among Prisoners in a Nigerian prison. BMC Gastroenterology, 20, Article No. 360. https://doi.org/10.1186/s12876-020-01504-8
[20]
Mendes-Corrêa, M. and Núñez, M. (2010) Management of HIV and Hepatitis Virus Coinfection. Expert Opinion on Pharmacotherapy, 11, 2497-2516. https://doi.org/10.1517/14656566.2010.500615
[21]
Agbakwuru, C. and Ibe-Godfrey, E.M. (2016) Incarceration & the Well-Being of Prison Inmates in Nigeria. British Journal of Education, 4, 81-87.
[22]
Nwaopara, U. and Stanley, P. (2015) Prevalence of Depression in Port Harcourt Prison. Journal of Psychiatry, 18, Article ID: 340.
[23]
Naing, L., Winn, T. and Rusli, B.N. (2006) Sample Size Calculator for Prevalence Studies. Archives of Orofacial Sciences, 1, 9-14.
[24]
Monday, I.E., Francis, J.I., Lamidi, B.T. and Mohammad, S.U. (2014) Investigating Urinary Schistosomiasis in Bali Town, Bali Local Government Area, Taraba State, Nigeria. Nigerian Journal of Parasitology, 35, 149-155.
[25]
Adjei, A.A., Armah, H.B., Gbagbo, F., Ampofo, W.K., Quaye, I.K., Hesse, I.F. and Mensah, G. (2006) Prevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Syphilis among Prison Inmates and Officers at Nsawam and Accra, Ghana. Journal of Medical Microbiology, 55, 593-597. https://doi.org/10.1099/jmm.0.46414-0
[26]
Kazi, A.M., Shah, S.A., Jenkins, C.A., Shepherd, B.E. and Vermund, S.H. (2010) Risk Factors and Prevalence of Tuberculosis, Human Immunodeficiency Virus, Syphilis, Hepatitis B Virus, and Hepatitis C Virus among Prisoners in Pakistan. International Journal of Infectious Diseases, 14, E60-E66. https://doi.org/10.1016/j.ijid.2009.11.012
[27]
Kassa, Y., Million, Y., Biset, S. and Moges, F. (2021) Hepatitis B and Hepatitis C Viral Infections and Associated Factors among Prisoners in Northeast Ethiopia. Journal of Blood Medicine, 12, 561-570. https://doi.org/10.2147/JBM.S314556
[28]
Nokhodian, Z., Yazdani, M.R., Yaran, M., Shoaei, P., Mirian, M., Ataei, B., Babak, A. and Ataie, M. (2012) Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C among Female Prisoners in Isfahan, Iran. Hepatitis Monthly, 12, 442-447. https://doi.org/10.5812/hepatmon.6144
[29]
Taleban, R., Moafi, M., Ataei, B., Yaran, M., Nokhodian, Z., Kassaian, N., Adibi, P. and Javadi, A. (2018) Seroprevalence of Hepatitis B Infection and Associated Risk Factors among Drug Users in Drop-in Centers of Isfahan, Iran. International Journal of Preventive Medicine, 9, 46. https://doi.org/10.4103/ijpvm.IJPVM_382_16
[30]
Puga, M.A.M., Bandeira, L.M., Pompilio, M.A., Croda, J., Rezende, G.R.D., Dorisbor, L.F.P., Tanaka, T.S.O., Cesar, G.A., Teles, S.A., Simionatto, S., Novais, A.R.T., et al. (2017) Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil. PLOS ONE, 12, e0169195. https://doi.org/10.1371/journal.pone.0169195
[31]
Ramamoorthy, M., Venketeswaran, A., Seenivasan, P., Revathy, M., Manimaran, M., Chitra, S., Malarvizhi, M. and Frederick, T. (2016) Risk Factors and Prevalence, Hepatitis B Virus and Hepatitis C Virus among Prison Inmates, Chennai, India, 2015. International Journal of Infectious Diseases, 53, 90. https://doi.org/10.1016/j.ijid.2016.11.227
[32]
Jaquet, A., Wandeler, G., Tine, J., Dagnra, C.A., Attia, A., Patassi, A., Ndiaye, A., de Ledinghen, V., Ekouevi, D.K., Seydi, M. and Dabis, F. (2016) HIV Infection, Viral Hepatitis, and Liver Fibrosis among Prison Inmates in West Africa. BMC Infectious Diseases, 16, Article No. 249. https://doi.org/10.1186/s12879-016-1601-4
[33]
Kose, S., Adar, P., Gozaydin, A., Kuzucu, L. and Akkoclu, G. (2019) Hepatitis B and Hepatitis C in Prisons: A Prevalence Study. International Journal of Prisoner Health, 15, 162-167. https://doi.org/10.1108/IJPH-01-2018-0004
[34]
Magri, M.C., Ibrahim, K.Y., Pinto, W.P., França, F.O.D.S., Bernardo, W.M. and Tengan, F.M. (2015) Prevalence of Hepatitis C Virus in Brazil’s Inmate Population: A Systematic Review. Revista de Saúde Pública, 49, 42-52. https://doi.org/10.1590/S0034-8910.2015049005886
[35]
Belaunzarán-Zamudio, P.F., Mosqueda-Gomez, J.L., Macias-Hernandez, A., Sierra-Madero, J.G., Ahmed, S. and Beyrer, C. (2017) Risk Factors for Prevalent Hepatitis C Virus Infection among Inmates in a State Prison System in Mexico. PLOS ONE, 12, e0179931. https://doi.org/10.1371/journal.pone.0179931
[36]
Kowo, M.P., Andoulo, F.A., Ngek, L.T., Sizimboue, D.T., Ndam, A.N., Ondo, B.E., Bagnaka, S.E., Djanteng, R., Ndam, E.C.N. and Njoya, O. (2019) Prevalence of Hepatitis C Virus and Associated Risk Factors among Inmates at New Bell Prison, Douala, Cameroon. Open Journal of Epidemiology, 9, 119-128. https://doi.org/10.4236/ojepi.2019.92011
[37]
Saiz De La Hoya, P., Marco, A., García-Guerrero, J., Rivera, A. and Prevalhep Study Group (2011) Hepatitis C and B Prevalence in Spanish Prisons. European Journal of Clinical Microbiology & Infectious Diseases, 30, 857-862. https://doi.org/10.1007/s10096-011-1166-5
[38]
Behzadifar, M., Gorji, H.A., Rezapour, A. and Bragazzi, N.L. (2018) Prevalence of Hepatitis C Virus Infection among Prisoners in Iran: A Systematic Review and Meta-Analysis. Harm Reduction Journal, 15, Article No. 24. https://doi.org/10.1186/s12954-018-0231-0
[39]
Petruzziello, A., Marigliano, S., Loquercio, G., Cozzolino, A. and Cacciapuoti, C. (2016) Global Epidemiology of Hepatitis C Virus Infection: An Up-Date of the Distribution and Circulation of Hepatitis C Virus Genotypes. World Journal of Gastroenterology, 22, 7824-7840. https://doi.org/10.3748/wjg.v22.i34.7824
[40]
Poulin, C., Alary, M., Lambert, G., Godin, G., Landry, S., Gagnon, H., Demers, E., Morarescu, E., Rochefort, J. and Claessens, C. (2007) Prevalence of HIV and Hepatitis C Virus Infections among Inmates of Quebec Provincial Prisons. CMAJ: Canadian Medical Association Journal (Journal de L’association Medicale Canadienne), 177, 252-256. https://doi.org/10.1503/cmaj.060760
